Edward J Tanenbaum
Overview
Explore the profile of Edward J Tanenbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen H, Li M, Xu N, Ng N, Sanchez E, Soof C, et al.
Leuk Res
. 2019 Apr;
81:62-66.
PMID: 31035033
B-cell maturation antigen (BCMA), a tumor necrosis factor receptor (TNFR) family member, is selectively expressed on terminally differentiated B-lymphocytes including multiple myeloma (MM) tumor cells. We sought to determine whether...
2.
Sanchez E, Li M, Patil S, Soof C, Nosrati J, Schlossberg R, et al.
Ann Hematol
. 2019 Jan;
98(3):691-703.
PMID: 30635766
The Janus kinase (JAK) pathway has been shown to play key roles in the growth and resistance to drugs that develop in multiple myeloma (MM) patients. The anti-MM effects of...
3.
Sanchez E, Tanenbaum E, Patil S, Li M, Soof C, Vidisheva A, et al.
Expert Rev Mol Diagn
. 2018 Mar;
18(4):319-329.
PMID: 29504446
B-cell maturation antigen (BCMA) is a cell membrane bound tumor necrosis factor receptor family member that is expressed exclusively on late stage normal and malignant B-cells and plasma cells. Addition...
4.
Sanchez E, Smith E, Yashar M, Patil S, Li M, Porter A, et al.
Target Oncol
. 2017 Dec;
13(1):39-47.
PMID: 29230672
B-cell maturation antigen (BCMA) was originally identified as a cell membrane receptor, expressed exclusively on late stage B-cells and plasma cells (PCs). Investigations of BCMA as a target for therapeutic...